Teva and Medincell Announce FDA Acceptance of Supplemental New Drug Application for UZEDY(R) (risperidone) Extended-Release Injectable Suspension as a Treatment for Patients with Bipolar I Disorder 26-02-2025, 04:00

Fluence Expands Digital Services Center; Leverages Digitization to Further Optimize Global Fleet of Assets 24-07-2024, 20:00

Heavy Rain Causing Plumbing Issues? Here's What to Do 27-02-2023, 04:07